bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangementsPAPAKONSTANTINOU, Georgios; VERBEKE, Caroline; HASTKA, Jan et al.British journal of haematology. 2001, Vol 113, Num 2, pp 383-390, issn 0007-1048Article

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-αSCHMIDT, Manuel; HOCHHAUS, Andreas; NITSCHE, Andreas et al.Blood. 2001, Vol 97, Num 11, pp 3648-3650, issn 0006-4971Article

Peritoneal haematopoiesis in acute panmyelosis with myelofibrosisMETZGEROTH, Georgia; REITER, Andreas; BACK, Walter et al.British journal of haematology. 2005, Vol 130, Num 1, issn 0007-1048, p. 1Article

Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disordersFRANK, Oliver; GIEHL, Michelle; CHUN ZHENG et al.Journal of virology. 2005, Vol 79, Num 17, pp 10890-10901, issn 0022-538X, 12 p.Article

Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Clinical chemistry and laboratory medicine. 2008, Vol 46, Num 3, pp 318-322, issn 1434-6621, 5 p.Article

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2REITER, Andreas; WALZ, Christoph; VANSTRAELEN, Danny et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2662-2667, issn 0008-5472, 6 p.Article

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapyHANFSTEIN, Benjamin; MÜLLER, Martin C; KREIL, Sebastian et al.Haematologica (Roma). 2011, Vol 96, Num 3, pp 360-366, issn 0390-6078, 7 p.Article

Diagnosis and therapy of polycythemia veraLENGFELDER, Eva; MERX, Kirsten; HEHLMANN, Rüdiger et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 3, pp 267-275, issn 0094-6176, 9 p.Article

Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patientHOFHEINZ, Ralf-Dieter; NGUYEN, Xuan-Duc; BUCHHEIDT, Dieter et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 3, pp 276-277, issn 0344-5704, 2 p.Article

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patientsBUCHHEIDT, Dieter; BAUST, Corinna; SKLADNY, Hevko et al.British journal of haematology. 2002, Vol 116, Num 4, pp 803-811, issn 0007-1048Article

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreHASFORD, Joerg; BACCARANI, Michele; SIMONSSON, Bengt et al.Blood. 2011, Vol 118, Num 3, pp 686-692, issn 0006-4971, 7 p.Article

Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast CancerFRANK, Oliver; VERBEKE, Caroline; SCHWARZ, Norbert et al.Journal of virology. 2008, Vol 82, Num 4, pp 1808-1818, issn 0022-538X, 11 p.Article

Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patientsSPIESS, Birgit; BUCHHEIDT, Dieter; BAUST, Corinna et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 5, pp 1811-1818, issn 0095-1137, 8 p.Article

Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide through glutathione-depletion in imatinib-resistant cellsKONIG, Heiko; HARTEL, Nicolai; SCHULTHEIS, Beate et al.Haematologica (Roma). 2007, Vol 92, Num 6, pp 838-841, issn 0390-6078, 4 p.Article

Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasiaMAYWALD, Ole; METZGEROTH, Georgia; SCHOCH, Claudia et al.British journal of haematology. 2002, Vol 119, Num 3, issn 0007-1048, p. 583Article

Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid LeukemiaBURCHERT, Andreas; MÜLLER, Martin C; KOSTREWA, Philippe et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1429-1435, issn 0732-183X, 7 p.Article

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1389-1393, issn 0390-6078, 5 p.Article

Detection of Aspergillus DNA by a nested PCR assay is superior to blood culture in an experimental murine model of invasive aspergillosisHUMMEL, Margit; BAUST, Corinna; KRETSCHMAR, Marianne et al.Journal of medical microbiology. 2004, Vol 53, Num 8, pp 803-806, issn 0022-2615, 4 p.Article

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αKREIL, Sebastian; WAGHORN, Katherine; ERNST, Thomas et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 148-152, issn 0390-6078, 5 p.Article

Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarraySEIFARTH, Wolfgang; FRANK, Oliver; ZEILFELDER, Udo et al.Journal of virology. 2005, Vol 79, Num 1, pp 341-352, issn 0022-538X, 12 p.Article

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β geneWALZ, Christoph; METZGEROTH, Georgia; CROSS, Nicholas C. P et al.Haematologica (Roma). 2007, Vol 92, Num 2, pp 163-169, issn 0390-6078, 7 p.Article

Expression of interferon regulatory factor 4 in chronic myeloid leukemia : Correlation with response to interferon alfa therapySCHMIDT, Manuel; HOCHHAUS, Andreas; KÖNIG-MEREDIZ, Sven A et al.Journal of clinical oncology. 2000, Vol 18, Num 19, pp 3331-3338, issn 0732-183XArticle

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaBURCHERT, Andreas; WÖLFL, Stefan; GSCHAIDMEIER, Harald et al.Blood. 2003, Vol 101, Num 1, pp 259-264, issn 0006-4971, 6 p.Article

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancerHOFHEINZ, Ralf-Dieter; VON GERSTENBERG-HELLDORF, Bolko; WENZ, Frederik et al.Journal of clinical oncology. 2005, Vol 23, Num 7, pp 1350-1357, issn 0732-183X, 8 p.Article

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNetGUILHOT, Joëlle; BACCARANI, Michele; ROUSSELOT, Philippe et al.Blood. 2012, Vol 119, Num 25, pp 5963-5971, issn 0006-4971, 9 p.Article